Susquehanna International Group
ESLAW icon

Susquehanna International Group’s Estrella Immunopharma Warrant ESLAW Stock Holding History

Susquehanna International Group’s Portfolio ESLAW Stock Details ESLAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,997
Closed -$728 – 12667
2025
Q3 		$728 Buy
+13,997
New +$598 ﹤0.01% 12212
2024
Q2 		– Sell
-23,753
Closed -$1.64K – 12315
2024
Q1 		$1.64K Buy
23,753
+1,267
+6% +$56 ﹤0.01% 11996
2023
Q4 		$675 Buy
22,486
+3,422
+18% +$267 ﹤0.01% 12205
2023
Q3 		$4.58K Sell
19,064
-59,317
-76% -$9.82K ﹤0.01% 11801
2023
Q2 		$4.35K Buy
78,381
+54,010
+222% +$3.69K ﹤0.01% 11835
2023
Q1 		$2.49K Buy
24,371
+1,809
+8% +$118 ﹤0.01% 12355
2022
Q4 		$1.17K Sell
22,562
-5,580
-20% -$466 ﹤0.01% 12172
2022
Q3 		$2K Sell
28,142
-193
-0.7% -$33 ﹤0.01% 12950
2022
Q2 		$9K Buy
+28,335
New +$6.29K ﹤0.01% 12526

Other funds holding ESLAW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Susquehanna International Group's ESLAW Position: Q4 2025 in Review

Susquehanna International Group sold out of Estrella Immunopharma Warrant (ESLAW) in Q4 2025, closing a stake of 13,997 shares — an estimated $728 sold.

Susquehanna International Group first reported a position in ESLAW in Q2 2022 and held it in 9 quarters. The position peaked at $9K in Q2 2022. 9 funds tracked by Wall St. Rank hold ESLAW as of Q4 2025.

  • Susquehanna International Group reported no remaining Estrella Immunopharma Warrant position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 13,997 Estrella Immunopharma Warrant shares in Q4 2025, an estimated $728.
  • Susquehanna International Group first reported a position in Estrella Immunopharma Warrant in Q2 2022 and held it in 9 quarters.
  • Susquehanna International Group's Estrella Immunopharma Warrant position peaked at $9K in Q2 2022.
  • 9 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.